<img src="https://ml.globenewswire.com/Resource/Download/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb?size=2" nborder="0" align="left" hspace="5" vspace="5" title="CRMD Logo.jpg" alt="CorMedix, Inc."/>PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026, and will host a corporate update conference call at 8:30am Eastern Time. <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2">Thursday, August 13th @ 8:30am ET</td></tr><tr><td style="max-width:30%; width:30%; min-width:30%;">Domestic:</td><td style="max-width:70%; width:70%; min-width:70%;">1-844-676-2922</td></tr><tr><td>International:</td><td>1-412-634-6840</td></tr><tr><td>Webcast:</td><td><a href="https://www.globenewswire.com/Tracker?data=lUpjhBoAmfN-CdHgiDaXHo30CPjI9G4dUIl-mF9SNeQcYt2TtQAhD2JGDaiayqOpY_chgrvOgSfY6BGHd9y3aR_x-Ww3fjjE2IGaIwwSRIdC9ZAxF89NrkhN5YA9v9nVF71kS4P4uBRPLOS7NK5Isw==" rel="nofollow" target="_blank" title="Webcast Link">Webcast Link</a></td></tr><tr><td> </td><td> </td></tr></table> About CorMedix CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: <a href="https://www.globenewswire.com/Tracker?data=4O_saOBMMDY1UgNw09d3yQMjnAwRtK2O3QpNtYojBTRlHOWbuQicmrXhtGyITUmzQPyFNdaQfaX5NEw5NE4ZFqeFQOVJYMU9SLeRBeNXL2M=" rel="nofollow" target="_blank" title="www.cormedix.com">www.cormedix.com</a>. Investor Contact: Dan Ferry Managing Director LifeSci Advisors <a href="https://www.globenewswire.com/Tracker?data=xhdufjHqV_SbHiOqMyDfxT6sXfqyTWTLS3kfY3WHYuPU6tnf28jLKklWiLqaIb0ZaBcyNYe0K-RZJ_b-aJBVVa3iABY90FhIR3I9oM9SfO3pc4JN6MUc5HBMPp-eI9Lr" rel="nofollow" target="_blank" title="daniel@lifesciadvisors.com">daniel@lifesciadvisors.com</a> (617) 430-7576 <img alt="" src='https://ml.globenewswire.com/media/MjEyOTNmODItMDQ4My00NzJjLTkzNDMtZTA5ZDI3NGY4N2JhLTUwMDA2NTY3OC0yMDI2LTA3LTI5LWVu/tiny/CorMedix-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn